Cite Filings / RAPP / 0001193125-26-005482

Feed Companies Filings Check

Sign in

424B5

Prospectus

Rapport Therapeutics, Inc. Filed 2026-01-07 Acc 0001193125-26-005482

Documents 1

424B5 Prospectus , d87801d424b5.htm

Around this filing

2026-10-27 424B5 Prospectus
2026-01-07 8-K Other events
2026-01-07 424B5 Prospectus
2026-01-07 8-K Regulation FD disclosure · Other events
2026-01-05 4 Chief Scientific Officer sold 6,567 shares at $30.05 ($197,338)
2026-01-05 4 Chief Development Officer sold 2,840 shares at $30.05 ($85,342)
2025-09-10 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d87801d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…